Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Indian J Public Health ; 66(2): 210-213, 2022.
Article in English | MEDLINE | ID: covidwho-1954320

ABSTRACT

Coronavirus disease 2019 pandemic has disrupted the antenatal care in low- and middle-income countries such as India. Telemedicine was introduced for the first time in India for continuing antenatal care. Hence, a questionnaire-based descriptive cross-sectional study is done to assess the outcomes of teleconsultation services, factors influencing it, and patient's perceived satisfaction. Three hundred and fifty-five women who delivered the following teleconsultation from July 2020 to October 2020 were included in the study. Thirty-two percent were high-risk pregnancies and 15% of the babies required neonatal intensive care unit admission. Ninety-eight percent could convey their health concerns, 18% had a referral to other departments, and 25% had visited casualty. Sixty-three percent procured medicine through e-prescription. Seventy-six percent were happy with teleconsultation overcrowded clinic, 82% were happy about saving travel expenditure, whereas overall satisfaction was 50%. Fourteen percent did not have access to smartphone and 9% did not receive the call at scheduled time. Telemedicine has a vital role in managing pregnancy concerns during this pandemic.


Subject(s)
COVID-19 , Remote Consultation , Cross-Sectional Studies , Female , Humans , India/epidemiology , Infant , Infant, Newborn , Pandemics , Patient Satisfaction , Pregnancy , Pregnant Women , Tertiary Care Centers
2.
International Journal of Ayurvedic Medicine ; 13(1):22-27, 2022.
Article in English | Web of Science | ID: covidwho-1849350

ABSTRACT

Background: On March 12, 2020, WHO declared Novel Coronavirus disease as a pandemic outbreak all over the world. The outbreak had led the medical sector to a new platform, in the implementation of ancient knowledge of the Siddha medicine in treatment, management, and prevention of this prevailing pandemic. According to Siddha science, any vitiation in the life force is the main cause of diseases in human beings. pandemic diseases caused due to infectious microorganisms are called 'Kona' Noigal' in various Siddha literatures. Aim and objective: To classify the Novel Coronavirus disease based on the Siddha Humoural principles and to elicit the changes of Ninety-six Thatthuvam (Ninety - six basic principles), Uyir Thathukkal and Udal Thathukkal. Materials and methods: This study is accomplished mainly for literature research. Various Siddha texts such as Sattamuni gnanam, Agathiyar Gunavagadam, Agathiyar vallathi Naadi, Theraiyar Sekarappa, etc. were referred. Numerous research articles on COVID 19 were critically reviewed from Scopus, PubMed, Google Scholar, etc. Discussion: By critically reviewing the signs and symptoms of COVID-19 with Siddha science, the authors had thrown light especially on the involvement of all basic components of the Tri thodam particularly Mukkutram verupadu (Tri humoral vitiation) in eliciting the pathogenesis of the disease. Conclusion: In this scientific review, the authors have attempted to comprehend the pathogenesis of Novel coronavirus disease in the context of Siddha's basic principles.

3.
Appl Soft Comput ; 115: 108250, 2022 Jan.
Article in English | MEDLINE | ID: covidwho-1561433

ABSTRACT

Coronavirus Disease 2019 (COVID-19) had already spread worldwide, and healthcare services have become limited in many countries. Efficient screening of hospitalized individuals is vital in the struggle toward COVID-19 through chest radiography, which is one of the important assessment strategies. This allows researchers to understand medical information in terms of chest X-ray (CXR) images and evaluate relevant irregularities, which may result in a fully automated identification of the disease. Due to the rapid growth of cases every day, a relatively small number of COVID-19 testing kits are readily accessible in health care facilities. Thus it is imperative to define a fully automated detection method as an instant alternate treatment possibility to limit the occurrence of COVID-19 among individuals. In this paper, a two-step Deep learning (DL) architecture has been proposed for COVID-19 diagnosis using CXR. The proposed DL architecture consists of two stages, "feature extraction and classification". The "Multi-Objective Grasshopper Optimization Algorithm (MOGOA)" is presented to optimize the DL network layers; hence, these networks have named as "Multi-COVID-Net". This model classifies the Non-COVID-19, COVID-19, and pneumonia patient images automatically. The Multi-COVID-Net has been tested by utilizing the publicly available datasets, and this model provides the best performance results than other state-of-the-art methods.

4.
Biocybern Biomed Eng ; 41(4): 1702-1718, 2021.
Article in English | MEDLINE | ID: covidwho-1474354

ABSTRACT

Coronavirus Diseases (COVID-19) is a new disease that will be declared a global pandemic in 2020. It is characterized by a constellation of traits like fever, dry cough, dyspnea, fatigue, chest pain, etc. Clinical findings have shown that the human chest Computed Tomography(CT) images can diagnose lung infection in most COVID-19 patients. Visual changes in CT scan due to COVID-19 is subjective and evaluated by radiologists for diagnosis purpose. Deep Learning (DL) can provide an automatic diagnosis tool to relieve radiologists' burden for quantitative analysis of CT scan images in patients. However, DL techniques face different training problems like mode collapse and instability. Deciding on training hyper-parameters to adjust the weight and biases of DL by a given CT image dataset is crucial for achieving the best accuracy. This paper combines the backpropagation algorithm and Whale Optimization Algorithm (WOA) to optimize such DL networks. Experimental results for the diagnosis of COVID-19 patients from a comprehensive COVID-CT scan dataset show the best performance compared to other recent methods. The proposed network architecture results were validated with the existing pre-trained network to prove the efficiency of the network.

5.
Viruses ; 13(5):24, 2021.
Article in English | MEDLINE | ID: covidwho-1209150

ABSTRACT

The emerging SARS-CoV-2 pandemic entails an urgent need for specific and sensitive high-throughput serological assays to assess SARS-CoV-2 epidemiology. We, therefore, aimed at developing a fluorescent-bead based SARS-CoV-2 multiplex serology assay for detection of antibody responses to the SARS-CoV-2 proteome. Proteins of the SARS-CoV-2 proteome and protein N of SARS-CoV-1 and common cold Coronaviruses (ccCoVs) were recombinantly expressed in E. coli or HEK293 cells. Assay performance was assessed in a COVID-19 case cohort (n = 48 hospitalized patients from Heidelberg) as well as n = 85 age- and sex-matched pre-pandemic controls from the ESTHER study. Assay validation included comparison with home-made immunofluorescence and commercial enzyme-linked immunosorbent (ELISA) assays. A sensitivity of 100% (95% CI: 86-100%) was achieved in COVID-19 patients 14 days post symptom onset with dual sero-positivity to SARS-CoV-2 N and the receptor-binding domain of the spike protein. The specificity obtained with this algorithm was 100% (95% CI: 96-100%). Antibody responses to ccCoVs N were abundantly high and did not correlate with those to SARS-CoV-2 N. Inclusion of additional SARS-CoV-2 proteins as well as separate assessment of immunoglobulin (Ig) classes M, A, and G allowed for explorative analyses regarding disease progression and course of antibody response. This newly developed SARS-CoV-2 multiplex serology assay achieved high sensitivity and specificity to determine SARS-CoV-2 sero-positivity. Its high throughput ability allows epidemiologic SARS-CoV-2 research in large population-based studies. Inclusion of additional pathogens into the panel as well as separate assessment of Ig isotypes will furthermore allow addressing research questions beyond SARS-CoV-2 sero-prevalence.

6.
Cognit Comput ; : 1-16, 2021 Jan 25.
Article in English | MEDLINE | ID: covidwho-1056082

ABSTRACT

The quick spread of coronavirus disease (COVID-19) has resulted in a global pandemic and more than fifteen million confirmed cases. To battle this spread, clinical imaging techniques, for example, computed tomography (CT), can be utilized for diagnosis. Automatic identification software tools are essential for helping to screen COVID-19 using CT images. However, there are few datasets available, making it difficult to train deep learning (DL) networks. To address this issue, a generative adversarial network (GAN) is proposed in this work to generate more CT images. The Whale Optimization Algorithm (WOA) is used to optimize the hyperparameters of GAN's generator. The proposed method is tested and validated with different classification and meta-heuristics algorithms using the SARS-CoV-2 CT-Scan dataset, consisting of COVID-19 and non-COVID-19 images. The performance metrics of the proposed optimized model, including accuracy (99.22%), sensitivity (99.78%), specificity (97.78%), F1-score (98.79%), positive predictive value (97.82%), and negative predictive value (99.77%), as well as its confusion matrix and receiver operating characteristic (ROC) curves, indicate that it performs better than state-of-the-art methods. This proposed model will help in the automatic screening of COVID-19 patients and decrease the burden on medicinal services frameworks.

7.
J Ambient Intell Humaniz Comput ; 12(9): 8887-8898, 2021.
Article in English | MEDLINE | ID: covidwho-1014246

ABSTRACT

The novel coronavirus disease (COVID-19) spread quickly worldwide, changing the everyday lives of billions of individuals. The preliminary diagnosis of COVID-19 empowers health experts and government professionals to break the chain of change and level the epidemic curve. The regular sort of COVID-19 detection test, be that as it may, requires specific hardware and generally has low sensitivity. Chest X-ray images to be used to diagnosis the COVID-19. In this work, a dataset of X-ray images with COVID-19, bacterial pneumonia, and normal was used to diagnose the COVID-19 automatically. This work to assess the execution of best in class Convolutional Neural Network (CNN) models proposed over ongoing years for clinical image classification. In particular, the modified pre-trained CNN-ResNet50 based Extreme Learning Machine classifier (ELM) has proposed for different diagnosis abnormalities such as COVID-19, Pneumonia, and normal. The proposed CNN method has trained and tested with the publicly available COVID-19, pneumonia, and normal datasets. The presented pre-trained ResNet CNN model provides accuracy, sensitivity, specificity, recall, precision, and F1 score values of 94.07, 98.15, 91.48, 85.21, 98.15, and 91.22, respectively, which is the best classification performance than other states of the art methods. This study introduced a computationally productive and exceptionally exact model for multi-class grouping of three diverse contamination types from alongside Normal people. This CNN model can help in the automatic diagnosis of COVID-19 cases and help decrease the burden on medicinal services frameworks.

8.
Appl Intell (Dordr) ; 51(3): 1351-1366, 2021.
Article in English | MEDLINE | ID: covidwho-777905

ABSTRACT

The quick spread of coronavirus disease (COVID-19) has become a global concern and affected more than 15 million confirmed patients as of July 2020. To combat this spread, clinical imaging, for example, X-ray images, can be utilized for diagnosis. Automatic identification software tools are essential to facilitate the screening of COVID-19 using X-ray images. This paper aims to classify COVID-19, normal, and pneumonia patients from chest X-ray images. As such, an Optimized Convolutional Neural network (OptCoNet) is proposed in this work for the automatic diagnosis of COVID-19. The proposed OptCoNet architecture is composed of optimized feature extraction and classification components. The Grey Wolf Optimizer (GWO) algorithm is used to optimize the hyperparameters for training the CNN layers. The proposed model is tested and compared with different classification strategies utilizing an openly accessible dataset of COVID-19, normal, and pneumonia images. The presented optimized CNN model provides accuracy, sensitivity, specificity, precision, and F1 score values of 97.78%, 97.75%, 96.25%, 92.88%, and 95.25%, respectively, which are better than those of state-of-the-art models. This proposed CNN model can help in the automatic screening of COVID-19 patients and decrease the burden on medicinal services frameworks.

SELECTION OF CITATIONS
SEARCH DETAIL